Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus immediate-release to modified-release conversion pharmacokinetic variability study in stable kidney transplant recipients
NL-OMON29529Active, not recruiting
- Sponsor
- Interne Geneeskunde, onderafdeling Nefrologie
- Start
- May 2010
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of tacrolimus in kidney transplant, sponsored by Interne Geneeskunde, onderafdeling Nefrologie. Primary endpoints: Intra-patient variability of tacrolimus AUC and Inter-patient variability of tacrolimus AUC. Started May 2010; status: active, not recruiting.
02
Drugs
tacrolimus
03
Conditions
kidney transplant
Beyond the preview
Go deeper on NL-OMON29529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON29529.